Browse > Article
http://dx.doi.org/10.4047/jkap.2018.56.4.391

A review of biocompatibility of zirconia: In vitro experiment  

Suh, Da-Won (School of Dentistry, Seoul National University)
Kim, Young-Kyun (Department of Oral & Maxillofacial Surgery, Seoul National University Bundang Hospital, Seongnam, School of Dentistry, Seoul National University)
Yi, Yang-Jin (Department of Prosthodontics, Seoul National University Bundang Hospital, Seongnam, School of Dentistry, Seoul National University)
Publication Information
The Journal of Korean Academy of Prosthodontics / v.56, no.4, 2018 , pp. 391-395 More about this Journal
Abstract
Increasing demands for zirconia material in clinics, assessment of biocompatibility of zirconia is essential. In this article, a review of in vitro studies of zirconia compatibility was performed. Zirconia showed great biocompatibility at in vitro studies with various cell lines such as fibroblasts, osteoblasts, and lymphocytes. Many studies reported that zirconia caused no cytotoxicity or mutation. Zirconia also showed less bacterial adhesion. There were no adverse effects except for small reduced strength with in vitro study mimicking long-term exposure of body fluid. According to the study with ostoblast-like cells, zirconia could regulate genes of immunity, molecular transport, and cell cycle. Such gene regulating was considered as one of the reasons of zirconia biocompatibility. With biocompatibility of zirconia powders, in vitro studies had controversial conclusions. It seems that zirconia powders might have cytotoxicity.
Keywords
Biocompatibility; Cytotoxicity; Zirconia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Dion I, Rouais F, Baquey C, Lahaye M, Salmon R, Trut L, Cazorla JP, Huong PV, Monties JR, Havlik P. Physico-chemistry and cytotoxicity of ceramics: part I: characterization of ceramic powders. J Mater Sci Mater Med 1997;8:325-32.   DOI
2 Ito A, Tateishi T, Niwa S, Tange S. In-vitro evaluation of the cytocompatibility of wear particles generated by UHMWPE/zirconia friction. Clin Mater 1993;12:203-9.   DOI
3 Catelas I, Petit A, Zukor DJ, Marchand R, Yahia L, Huk OL. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro. Biomaterials 1999;20:625-30.   DOI
4 Li J, Liu Y, Hermansson L, Soremark R. Evaluation of biocompatibility of various ceramic powders with human fibroblasts in vitro. Clin Mater 1993;12:197-201.   DOI
5 Nkamgueu EM, Adnet JJ, Bernard J, Zierold K, Kilian L, Jallot E, Benhayoune H, Bonhomme P. In vitro effects of zirconia and alumina particles on human blood monocyte-derived macrophages: X-ray microanalysis and flow cytometric studies. J Biomed Mater Res 2000;52:587-94.   DOI
6 Kosmac T, Oblak C, Jevnikar P, Funduk N, Marion L. The effect of surface grinding and sandblasting on flexural strength and reliability of Y-TZP zirconia ceramic. Dent Mater 1999;15:426-33.   DOI
7 Al-Amleh B, Lyons K, Swain M. Clinical trials in zirconia: a systematic review. J Oral Rehabil 2010;37:641-52.
8 Manicone PF, Rossi Iommetti P, Raffaelli L, Paolantonio M, Rossi G, Berardi D, Perfetti G. Biological considerations on the use of zirconia for dental devices. Int J Immunopathol Pharmacol 2007;20:9-12.
9 Josset Y, Oum'Hamed Z, Zarrinpour A, Lorenzato M, Adnet JJ, Laurent-Maquin D. In vitro reactions of human osteoblasts in culture with zirconia and alumina ceramics. J Biomed Mater Res 1999;47:481-93.   DOI
10 Lohmann CH, Dean DD, Koster G, Casasola D, Buchhorn GH, Fink U, Schwartz Z, Boyan BD. Ceramic and PMMA particles differentially affect osteoblast phenotype. Biomaterials 2002;23:1855-63.   DOI
11 Sterner T, Schutze N, Saxler G, Jakob F, Rader CP. Effects of clinically relevant alumina ceramic, zirconia ceramic and titanium particles of different sizes and concentrations on TNFalpha release in a human macrophage cell line. Biomed Tech (Berl) 2004;49:340-4.
12 Tateishi T, Ushida T, Aoki H. Round robin test for standardization of biocompatibility test procedure by cell culture method. Adv Biomater 1992;10:89-97.
13 Silva VV, Lameiras FS, Lobato ZI. Biological reactivity of zirconia-hydroxyapatite composites. J Biomed Mater Res 2002;63:583-90.   DOI
14 Carinci F, Pezzetti F, Volinia S, Francioso F, Arcelli D, Farina E, Piattelli A. Zirconium oxide: analysis of MG63 osteoblastlike cell response by means of a microarray technology. Biomaterials 2004;25:215-28.   DOI
15 Garvie RC, Urbani C, Kennedy DR, McNeuer JC. Biocompatibility of Magnesia Partially Stabilized Zirconia (Mg-PSZ) Ceramics. J Mater Sci 1984;19:3224-8.   DOI
16 Rimondini L, Cerroni L, Carrassi A, Torricelli P. Bacterial colonization of zirconia ceramic surfaces: an in vitro and in vivo study. Int J Oral Maxillofac Implants 2002;17:793-8.
17 Covacci V, Bruzzese N, Maccauro G, Andreassi C, Ricci GA, Piconi C, Marmo E, Burger W, Cittadini A. In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic. Biomaterials 1999;20:371-6.   DOI
18 Fassina P, Zaghini N, Bukat A, Piconi C, Greco F, Piantelli S. Yttria and calcia partially stabilized zirconia for biomedical applications. In: Ravaglioli A., Krajewski A, eds. Bioceramics and the human body. Netherlands; Springer; 1992. p. 223-9.